LYPD4 and pneumonia: Elevated levels of sMR have been observed in patients with various inflammatory conditions, such as pneumonia (Kazuo et al., 2019) and sepsis (Kjærgaard et al., 2014), suggesting that sMR could serve as a novel biomarker for inflammation.